SS1 (dsFv) PE38
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SS1 (dsFv) PE38, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma [Phase 1]